Same Indication

Icodextrin vs Rituximab

Icodextrin vs Rituximab: Overview

This comparison examines the pharmacological differences between Icodextrin and Rituximab.

Mechanism of Action

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Rituximab β€” 22 days.

Chemical Properties

Type: Icodextrin β€” Unknown; Rituximab β€” Antibody.